Literature DB >> 18198348

Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells.

Kazuhito Gotoh1, Yoshihiko Tanaka, Akihiko Nishikimi, Ayumi Inayoshi, Munechika Enjoji, Ryoichi Takayanagi, Takehiko Sasazuki, Yoshinori Fukui.   

Abstract

The migratory properties of dendritic cells (DCs) are important for their functions. Although several chemokines and their receptors have been implicated in DC migration, the downstream signaling molecules are largely unknown. Here we show that DOCK2, a hematopoietic cell-specific CDM family protein, is indispensable for migration of plasmacytoid DCs (pDCs), but not myeloid DCs (mDCs). Although DOCK2-deficiency did not affect development of pDCs, DOCK2-deficient (DOCK2(-/-)) mice exhibited a severe reduction of pDCs in the spleen and lymph nodes. Adoptive transfer experiments revealed that DOCK2(-/-) pDCs failed to migrate into the periarteriolar lymphoid sheaths of the spleen. In DOCK2(-/-) pDCs, chemokine-induced Rac activation was severely impaired, resulting in the reduction of motility and the loss of polarity during chemotaxis. In contrast, DOCK2(-/-) mDCs did not show any defects in Rac activation and migration. These results indicate that pDCs and mDCs use distinct molecules to activate Rac during chemotaxis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18198348     DOI: 10.1182/blood-2007-09-112169

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  38 in total

1.  Opening up on ELMO regulation: New insights into the control of Rac signaling by the DOCK180/ELMO complex.

Authors:  Manishha Patel; Ariane Pelletier; Jean-François Côté
Journal:  Small GTPases       Date:  2011-09-01

2.  DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses.

Authors:  Yosuke Harada; Yoshihiko Tanaka; Masao Terasawa; Markus Pieczyk; Katsuyoshi Habiro; Tomoya Katakai; Kyoko Hanawa-Suetsugu; Mutsuko Kukimoto-Niino; Tomoko Nishizaki; Mikako Shirouzu; Xuefeng Duan; Takehito Uruno; Akihiko Nishikimi; Fumiyuki Sanematsu; Shigeyuki Yokoyama; Jens V Stein; Tatsuo Kinashi; Yoshinori Fukui
Journal:  Blood       Date:  2012-03-28       Impact factor: 22.113

3.  ASCertaining cytoskeletal rearrangements in antigen presentation and migration.

Authors:  Ioannis Karakasiliotis; Dimitris L Kontoyiannis
Journal:  Nat Immunol       Date:  2011-09-20       Impact factor: 25.606

4.  DOCK8 Protein Regulates Macrophage Migration through Cdc42 Protein Activation and LRAP35a Protein Interaction.

Authors:  Akira Shiraishi; Takehito Uruno; Fumiyuki Sanematsu; Miho Ushijima; Daiji Sakata; Toshiro Hara; Yoshinori Fukui
Journal:  J Biol Chem       Date:  2016-12-27       Impact factor: 5.157

5.  Addendum: defective Dock2 expression in a subset of ASC-deficient mouse lines.

Authors:  Sirish K Ippagunta; R K Subbarao Malireddi; Patrick J Shaw; Geoffrey A Neale; Lieselotte Vande Walle; Yoshinori Fukui; Douglas R Green; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  Nat Immunol       Date:  2012-07       Impact factor: 25.606

6.  Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses.

Authors:  Whitney E Purtha; Melissa Swiecki; Marco Colonna; Michael S Diamond; Deepta Bhattacharya
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

Review 7.  Immune pathology associated with altered actin cytoskeleton regulation.

Authors:  Dilki C Wickramarachchi; Argyrios N Theofilopoulos; Dwight H Kono
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

8.  Phospholipase C gamma 2 is critical for development of a murine model of inflammatory arthritis by affecting actin dynamics in dendritic cells.

Authors:  Viviana Cremasco; Elisa Benasciutti; Marina Cella; Marina Kisseleva; Monica Croke; Roberta Faccio
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

9.  Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.

Authors:  Kazuhito Gotoh; Yoshihiko Tanaka; Akihiko Nishikimi; Risa Nakamura; Hisakata Yamada; Naoyoshi Maeda; Takahiro Ishikawa; Katsuaki Hoshino; Takehito Uruno; Qinhong Cao; Sadayuki Higashi; Yasushi Kawaguchi; Munechika Enjoji; Ryoichi Takayanagi; Tsuneyasu Kaisho; Yasunobu Yoshikai; Yoshinori Fukui
Journal:  J Exp Med       Date:  2010-03-15       Impact factor: 14.307

10.  DOCK2 Sets the Threshold for Entry into the Virtual Memory CD8+ T Cell Compartment by Negatively Regulating Tonic TCR Triggering.

Authors:  Vinay S Mahajan; Ezana Demissie; Faisal Alsufyani; Sudha Kumari; Grace J Yuen; Vinayak Viswanadham; Andrew Huang; Johnson Q Tran; James J Moon; Darrell J Irvine; Shiv Pillai
Journal:  J Immunol       Date:  2019-11-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.